Rosendahl, I <br/><br/>
Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer.  [electronic resource] 

 -  The Prostate  Feb 1999 
 - 100-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0270-4137 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0045(19990201)38:2<100::aid-pros3>3.0.co;2-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Combined Modality Therapy<br/>Flutamide--therapeutic use<br/>Goserelin--therapeutic use<br/>Humans<br/>Male<br/>Neoplasm Metastasis<br/>Orchiectomy<br/>Pain Measurement<br/>Prostatic Neoplasms--pathology<br/>Quality of Life<br/>Quality-Adjusted Life Years<br/>Survival Analysis